Rituximab and Involved Field Radiotherapy in Early Stage Follicular Lymphoma

NCT00509184 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

85

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma, Malignant

Interventions

DRUG: Rituximab

Sponsor

Klaus Herfarth, MD

Collaborators

[object Object]
[object Object]